855
Views
17
CrossRef citations to date
0
Altmetric
Miscellany

Diagnosing lung cancer using etoposide microparticles labeled with 99mTc

, , , , , , & show all
Pages 341-345 | Received 04 Feb 2017, Accepted 14 Mar 2017, Published online: 30 Mar 2017

Figures & data

Table 1. Percentage of labeled etoposide microparticles by ascending chromatograms of 99mTc compared with free pertechnetate (Na99mTcO4) in 2 h.

Table 2. Percentage of labeled etoposide microparticles by ascending chromatograms of 99mTc compared with free pertechnetate (Na99mTcO4) in 8 h.

Figure 1. Etoposide microparticle mean size and size distribution.

Figure 1. Etoposide microparticle mean size and size distribution.

Figure 2. SEM image. The figure “A” is an immediate image, the “B” is after labeling with 99mTc and “C” is 1 month after labeling with 99mTc.

Figure 2. SEM image. The figure “A” is an immediate image, the “B” is after labeling with 99mTc and “C” is 1 month after labeling with 99mTc.

Figure 3. Biodistribution of labeled etoposide microparticles in inducted mice with lung cancer (xenograph model). The y-axis is the dose in μCi and the x-axis is the organ. Is important to observe that lesion means xenograph lung tumor.

Figure 3. Biodistribution of labeled etoposide microparticles in inducted mice with lung cancer (xenograph model). The y-axis is the dose in μCi and the x-axis is the organ. Is important to observe that lesion means xenograph lung tumor.

Figure 4. SPECT imaging of Balb/c nude mouse inducted with xenograft cancer model in the back.

Figure 4. SPECT imaging of Balb/c nude mouse inducted with xenograft cancer model in the back.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.